Tradestie Institutional Equity Comparison Engine
SER vs PLYX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SER Overall Edge
SER Captures Institutional Edge (2โ0 Pillars ยท 6โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Serina Therapeutics, Inc. (SER) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, SER trades at N/M Forward P/E with 0.0% operating margin (+154.9% YoY revenue) versus PLYX at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, SER sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PLYX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SER N/M vs PLYX N/M Fwd P/E
Growth & Margin Winner
SER
Op Margin 0.0% vs N/A ยท YoY +154.9% vs N/A
Momentum & Technical Winner
SER
1Y -68.1% vs -95.7% ยท 52W Pos 2% vs 0%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SER
NYSE American
Serina Therapeutics, Inc.
Pharmaceutical Preparations
$1.20
-11.11% 1D
Market Cap
$35.9M
1M Return
-32.2%
1Y Return
-68.09%
Forward P/E
N/M
Unified AI Score
43.1 / 100
HOLD
Tech 25.0
Fund 57.0
Flow 50.0
Mom 59.0
PLYX
US Equity
PLYX
Institutional Equity
$1.51
-6.21% 1D
Market Cap
N/A
1M Return
-22.16%
1Y Return
-95.69%
Forward P/E
N/M
Unified AI Score
43.3 / 100
HOLD
Tech 33.0
Fund 52.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SER -68.09%
PLYX -95.69%
Spread: +39.81 pp (SER Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
SER TTM Op. Margin: 0.0%
PLYX TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SER vs PLYX. Trailing 12-month operating profitability (SER 0.0% vs PLYX N/A) and valuation multiples (SER N/M vs PLYX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SER | PLYX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $35.9M | N/A | Larger Scale | SER |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +154.9% | N/A | Higher Growth | SER |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | SER |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | SER |
| Return on Equity (ROE) Capital Efficiency | -207.9% | N/A | Higher ROE | SER |
| 52-Week Range Position Momentum | 2% ($1โ$4) | 0% ($2โ$49) | Stronger Trend | SER |
| Beta / 30D Volatility Risk Regime | 1.40ฮฒ ยท 98% Vol | 1.43ฮฒ ยท 60% Vol | Lower Realized Risk | PLYX |
| Unified Institutional Score Composite Signal | 43.1 / 100 (HOLD) | 43.3 / 100 (HOLD) | Higher Composite | Tie |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SER vs PLYX Buy Guide
SER
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
PLYX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SER nor PLYX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.